1. Home
  2. PROF vs MXCT Comparison

PROF vs MXCT Comparison

Compare PROF & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.60

Market Cap

189.2M

Sector

Health Care

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.47

Market Cap

186.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROF
MXCT
Founded
N/A
1999
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.2M
186.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PROF
MXCT
Price
$6.60
$1.47
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$11.00
$7.50
AVG Volume (30 Days)
100.8K
1.5M
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,297,000.00
$34,419,000.00
Revenue This Year
$64.23
N/A
Revenue Next Year
$113.06
$10.69
P/E Ratio
N/A
N/A
Revenue Growth
67.94
N/A
52 Week Low
$3.76
$1.26
52 Week High
$8.36
$5.20

Technical Indicators

Market Signals
Indicator
PROF
MXCT
Relative Strength Index (RSI) 57.49 41.45
Support Level $6.09 $1.45
Resistance Level $7.04 $1.80
Average True Range (ATR) 0.42 0.12
MACD 0.02 -0.02
Stochastic Oscillator 70.27 14.42

Price Performance

Historical Comparison
PROF
MXCT

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: